Biological significance of perineural invasion (PNI) in prostate cancer

Prostate

Volumn 72, Issue 5, 2012, Pages 542-548

  Fromont, Gaëlle ^a   Godet, Julie ^a   Pires, Christophe ^a   Yacoub, Mokrane ^a   Dore, Bertrand ^a   Irani, Jacques ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

perineural invasion; prostate cancer; tissue microarrays

Indexed keywords

CD74 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; KI 67 ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; NEU DIFFERENTIATION FACTOR;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PERINEURIUM; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL PROLIFERATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KI-67 ANTIGEN; MALE; NEOPLASM INVASIVENESS; NEUREGULIN-1; PERIPHERAL NERVES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84857505886     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21456     Document Type: Article

References (28)

1. Powell MS, Li R, Dai H, Sayeeduddin M, Wheeler TM, Ayala GE,. Neuroanatomy of the normal prostate. Prostate 2005; 65: 52-57.
2. Martinez-Pineiro L, Dahiya R, Nunes LL, Tanagho EA, Schmidt RA,. Pelvic plexus denervation in rats causes morphologic and functional changes of the prostate. J Urol 1993; 150: 215-218.
3. Wang JM, McKenna KE, McVary KT, Lee C,. Requirement of innervation for maintenance of structural and functional integrity in the rat prostate. Biol Reprod 1991; 44: 1171-1176.
4. Marchesi F, Piemonti L, Mantovani A, Allavena P,. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev 2010; 21 (1): 77-82.
5. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D,. Perineural invasion in cancer: A review of the literature. Cancer 2009; 115 (15): 3379-3391.
6. Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, Mason MD,. The prognostic significance of perineural invasion in prostatic cancer biopsies: A systematic review. Cancer 2007; 109 (1): 13-24.
7. Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, Tsunoda T, Suzuki T, Monden M, Saitoh Y, Yamauchi H, Ogata Y,. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 1999; 29: 16-22.
8. Endrizzi J, Seay T,. The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer. BJU Int 2000; 85: 696-698.
9. Ozcan F,. Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure. Eur Urol 2001; 40: 308-312.
10. Ayala GE, Dai H, Ittmann M, Li R, Powell M, Frolov A, Wheeler TM, Thompson TC, Rowley D,. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 2004; 64: 6082-6090.
11. Ayala GE, Dai H, Tahir SA, Li R, Timme T, Ittmann M, Frolov A, Wheeler TM, Rowley D, Thompson TC,. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res 2006; 66 (10): 5159-5164.
12. Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM, Rowley D,. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 2008; 14 (23): 7593-7603.
13. de Muga S, Hernández S, Agell L, Salido M, Juanpere N, Lorenzo M, Lorente JA, Serrano S, Lloreta J,. Molecular alterations of EGFR and PTEN in prostate cancer: Association with high-grade and advanced-stage carcinomas. Mod Pathol 2010; 23 (5): 703-712.
14. Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F,. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen independence in human prostate cancer. Clin Cancer Res 2002; 8: 3438-3444.
15. Schafer W, Funke PJ, Kunde D, Rausch U, Wennemuth G, Stützer H,. Intensity of androgen and epidermal growth factor receptor immunoreactivity in samples of radical prostatectomy as prognostic indicator: Correlation with clinical data of long-term observations. J Urol 2006; 176: 532-537.
16. Bockman DE, Büchler M, Beger HG,. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology 1994; 107 (1): 219-230.
17. Soler M, Mancini F, Meca-Cortés O, Sánchez-Cid L, Rubio N, Lõpez-Fernández S, Lozano JJ, Blanco J, Fernández PL,. Thomson TM. HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells. Int J Cancer 2009; 125 (11): 2565-2575.
18. Birchmeier C,. ErbB receptors and the development of the nervous system. Exp Cell Res 2009; 315 (4): 611-618.
19. Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL,. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 2006; 177: 8730-8739.
20. Koide N, Yamada T, Shibata R, Mori T, Fukuma M, Yamazaki K, Aiura K, Shimazu M, Hirohashi S, Nimura Y, Sakamoto M,. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Clin Cancer Res 2006; 12 (8): 2419-2426.
21. Nishio Y, Nishihira J, Ishibashi T, Kato H, Minami A,. Role of macrophage migration inhibitory factor (MIF) in peripheral nerve regeneration: Anti-MIF antibody induces delay of nerve regeneration and the apoptosis of Schwann cells. Mol Med 2002; 8 (9): 509-520.
22. Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM,. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol 2001; 32: 828-833.
23. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, Ittmann M,. Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res 2009; 15 (12): 3979-3989.
24. Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JE,. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1: p53 mouse tumor model. Cancer Res 2002; 62 (15): 4507-4513.
25. Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R,. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Cancer J Sci Am 1997; 3: 21-30.
26. Zhang Z, Prentiss L, Heitzman D, Stahl RC, DiPino F Jr, Carey DJ,. Neuregulin isoforms in dorsal root ganglion neurons: Effects of the cytoplasmic domain on localization and membrane shedding of Nrg-1 type I. J Neurosci Res 2006; 84 (1): 1-12.
27. Arcuri F, del Vecchio MT, de Santi MM, Lalinga AV, Pallini V, Bini L, Bartolommei S, Parigi S, Cintorino M,. Macrophage migration inhibitory factor in the human prostate: Identification and immunocytochemical localization. Prostate 1999; 39 (3): 159-165.
28. Henne C, Schwenk F, Koch N, Moller P,. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology 1995; 84: 177-182.